Daoyan Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Daoyan Liu has a total of 116 co-authors. Here are the top co-authors by number of shared publications:
- Zhiming Zhu
Affiliations Department of Hypertension and Endocrinology, Center for Hypertension and Metabolic Diseases, Daping Hospital, Army Medical University, Chongqing Institute of Hypertension, Chongqing, China, Chongqing Institute for Brain and Intelligence, Chongqing, China
5 shared publications Qianran Wang
3 shared publicationsShaoyang Lin
3 shared publicationsWeijie Xia
3 shared publicationsHongbo He
Department of Hypertension and Endocrinology, Center for Hypertension and Metabolic Diseases, Daping Hospital, Chongqing Institute of Hypertension, Army Medical University, Chongqing, China
2 shared publicationsLijuan Wang
Department of Hypertension and Endocrinology, Center for Hypertension and Metabolic Diseases, Daping Hospital, Chongqing Institute of Hypertension, Army Medical University, Chongqing, China
2 shared publications
Latest Publications
- Open Access
- 25 March 2026
- Published by Elsevier in Cell Reports
- Vol. 45 (4) , 117104
Gut glucose assimilation governs glucose homeostasis through reciprocal interaction between glucose and amino acid transporter
- 25 March 2026
- Published by Elsevier in Cell Reports
- Vol. 45 (4) , 117104
Open AccessGut glucose assimilation governs glucose homeostasis through reciprocal interaction between glucose and amino acid transporter
- 31 May 2024
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 37 (9) , 708-716
Dietary Cinnamaldehyde Activation of TRPA1 Antagonizes High-Salt-Induced Hypertension Through Restoring Renal Tubular Mitochondrial Dysfunction
Renal proximal tubule plays a pivotal role in regulating sodium reabsorption and thus blood pressure. Transient receptor potential ankyrin 1 (TRPA1) has been reported to protect against renal injury by modulating mitochondrial function. We hypothesize that the activation of TRPA1 by its agonist cinnamaldehyde may mitigates high salt intake induced hypertension by inhibiting urinary sodium reabsorption through restoration of renal tubular epithelial mitochondrial function. Trpa1-deficient (Trpa1-/-) mice and wild-type (WT) mice were fed standard laboratory chow [normal diet (ND) group, 0.4% salt], standard laboratory chow with 8% salt [high-salt diet (HS) group] or standard laboratory chow with 8% salt plus 0.015% cinnamaldehyde [high-salt plus cinnamaldehyde diet (HSC) group] for six months. Urinary sodium excretion, ROS production, mitochondrial function and the expression of NHE3 and Na+/K+-ATPase of renal proximal tubules were determined. Chronic dietary cinnamaldehyde supplementation reduced tail systolic blood pressure and 24-hour ambulatory arterial pressure in HS-fed WT mice. Compared with the mice fed HS, cinnamaldehyde supplementation significantly increased urinary sodium excretion, inhibited excess ROS production and alleviated mitochondrial dysfunction of renal proximal tubules in WT mice. However, these effects of cinnamaldehyde were absent in Trpa1-/- mice. Furthermore, chronic dietary cinnamaldehyde supplementation blunted HS-induced upregulation of NHE3 and Na+/K+-ATPase in WT mice but not Trpa1-/- mice. The present study demonstrated that chronic activation of Trpa1 attenuates HS-induced hypertension by inhibiting urinary sodium reabsorption through restoring renal tubular epithelial mitochondrial function. Renal TRPA1 may be a potential target for the management of excessive dietary salt intake-associated hypertension.
- 31 May 2024
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 37 (9) , 708-716
Dietary Cinnamaldehyde Activation of TRPA1 Antagonizes High-Salt-Induced Hypertension Through Restoring Renal Tubular Mitochondrial Dysfunction
Renal proximal tubule plays a pivotal role in regulating sodium reabsorption and thus blood pressure. Transient receptor potential ankyrin 1 (TRPA1) has been reported to protect against renal injury by modulating mitochondrial function. We hypothesize that the activation of TRPA1 by its agonist cinnamaldehyde may mitigates high salt intake induced hypertension by inhibiting urinary sodium reabsorption through restoration of renal tubular epithelial mitochondrial function. Trpa1-deficient (Trpa1-/-) mice and wild-type (WT) mice were fed standard laboratory chow [normal diet (ND) group, 0.4% salt], standard laboratory chow with 8% salt [high-salt diet (HS) group] or standard laboratory chow with 8% salt plus 0.015% cinnamaldehyde [high-salt plus cinnamaldehyde diet (HSC) group] for six months. Urinary sodium excretion, ROS production, mitochondrial function and the expression of NHE3 and Na+/K+-ATPase of renal proximal tubules were determined. Chronic dietary cinnamaldehyde supplementation reduced tail systolic blood pressure and 24-hour ambulatory arterial pressure in HS-fed WT mice. Compared with the mice fed HS, cinnamaldehyde supplementation significantly increased urinary sodium excretion, inhibited excess ROS production and alleviated mitochondrial dysfunction of renal proximal tubules in WT mice. However, these effects of cinnamaldehyde were absent in Trpa1-/- mice. Furthermore, chronic dietary cinnamaldehyde supplementation blunted HS-induced upregulation of NHE3 and Na+/K+-ATPase in WT mice but not Trpa1-/- mice. The present study demonstrated that chronic activation of Trpa1 attenuates HS-induced hypertension by inhibiting urinary sodium reabsorption through restoring renal tubular epithelial mitochondrial function. Renal TRPA1 may be a potential target for the management of excessive dietary salt intake-associated hypertension.
- Open Access
- 1 January 2020
- Published by Wolters Kluwer Health in Hypertension
- Vol. 75 (1) , 150-162
Activation of Transient Receptor Potential Channel Vanilloid 4 by DPP-4 (Dipeptidyl Peptidase-4) Inhibitor Vildagliptin Protects Against Diabetic Endothelial Dysfunction
Endothelial dysfunction is an early step to the progression of cardiovascular diseases in diabetes. Apart from their anti-diabetic action, DPP-4 (dipeptidyl peptidase-4) inhibitors also reduce cardiovascular events in diabetic patients. However, the underlying mechanism of the beneficial effect of DPP-4 inhibitor on endothelial function is still obscure. In this study, we intervened type 1 or 2 diabetic model mice with vildagliptin for 4 weeks and measured the vascular reactivity. We found that vildagliptin improved endothelium-dependent vasodilation in diabetic mice independent of GLP-1 (glucagonlike peptide-1), but this effect was blocked by a SIRT1 (Sirtuin 1) inhibitor, Ex527. Mechanistically, vildagliptin-activated Transient Receptor Potential Channel Vanilloid 4 (TRPV4) to promote extracellular calcium uptake in endothelial cells, which activated AMPK (AMP-activated protein kinase)/SIRT1 pathway to counteract hyperglycemia-induced endothelial reactive oxygen species generation and senescence. Vildagliptin directly binds to TRPV4 by forming a hydrogen bond, which is critical to vildagliptin-evoked endothelial calcium intake. Knockout or inhibition of TRPV4 erased the beneficial role of vildagliptin. In addition, activation of SIRT1 by SRT1720 improved endothelial function independent of TRPV4 and reduced TRPV4 transcription to maintain an appropriate calcium level. In summary, our findings prove that vildagliptin protects against hyperglycemia-induced endothelial dysfunction by activating TRPV4-meditaed Ca 2+ uptake, which helps to re-understand the mechanism of DPP-4 inhibitors and expand the therapeutic scope.
- 1 January 2020
- Published by Wolters Kluwer Health in Hypertension
- Vol. 75 (1) , 150-162
Open AccessActivation of Transient Receptor Potential Channel Vanilloid 4 by DPP-4 (Dipeptidyl Peptidase-4) Inhibitor Vildagliptin Protects Against Diabetic Endothelial Dysfunction
Endothelial dysfunction is an early step to the progression of cardiovascular diseases in diabetes. Apart from their anti-diabetic action, DPP-4 (dipeptidyl peptidase-4) inhibitors also reduce cardiovascular events in diabetic patients. However, the underlying mechanism of the beneficial effect of DPP-4 inhibitor on endothelial function is still obscure. In this study, we intervened type 1 or 2 diabetic model mice with vildagliptin for 4 weeks and measured the vascular reactivity. We found that vildagliptin improved endothelium-dependent vasodilation in diabetic mice independent of GLP-1 (glucagonlike peptide-1), but this effect was blocked by a SIRT1 (Sirtuin 1) inhibitor, Ex527. Mechanistically, vildagliptin-activated Transient Receptor Potential Channel Vanilloid 4 (TRPV4) to promote extracellular calcium uptake in endothelial cells, which activated AMPK (AMP-activated protein kinase)/SIRT1 pathway to counteract hyperglycemia-induced endothelial reactive oxygen species generation and senescence. Vildagliptin directly binds to TRPV4 by forming a hydrogen bond, which is critical to vildagliptin-evoked endothelial calcium intake. Knockout or inhibition of TRPV4 erased the beneficial role of vildagliptin. In addition, activation of SIRT1 by SRT1720 improved endothelial function independent of TRPV4 and reduced TRPV4 transcription to maintain an appropriate calcium level. In summary, our findings prove that vildagliptin protects against hyperglycemia-induced endothelial dysfunction by activating TRPV4-meditaed Ca 2+ uptake, which helps to re-understand the mechanism of DPP-4 inhibitors and expand the therapeutic scope.
- 1 September 2016
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 34 (Supplement) , e404
OS 36-09 DEFICIENCY OF THERMOGENESIS AND HEAT SENSATION ACCELERATES OBESITY AND HIGH BLOOD PRESSURE
Obesity is global healthy problem. Uncoupling protein 1 (UCP1) mainly expresses on brown adipose tissue (BAT), uncouples energy substrate oxidation from mitochondrial ATP production and results in the loss of potential energy as heat. Transient receptor potential vanilloid subfamily, member 1 (TRPV1) is the heat-gated cation ion channel. The aim of this study was to investigate the in vivo role of TRPV1 and UCP1 co-action in obesity. We generated and characterized UCP1−/− mice lacking TRPV1 activity (TRPV1−/−/UCP1−/− mice). The core-body temperature and the locomotor activity were simultaneously measured by the telemetry system. The rate of mitochondrial respiration was measured using the Oxygraph-2k. Cytosol superoxide anion was determined by DHE and mitochondrial superoxide anion was measured by MitoSOX. The levels of ATP in primary cultured brown adipocytes were measured using a firefly luciferase-based ATP assay kit. Primary brown adipocytes were cultured and the fluorescence measurements of cells were made using a fluorescent plate reader. TRPV1 and UCP1 double knockout would appear obesity in advance and more severe comparing with WT, TRPV1−/− and UCP1−/− mice. TRPV1 and UCP1 double knockout in mice reduced functional BAT generation to cause BAT white, and decreased lipolysis comparing with the other three groups. TRPV1−/−/UCP1−/− mice significantly decreased resting oxygen consumptions, heat production and locomotor activities. Mitochondrial respiratory function seriously disordered in BAT of TRPV1−/−/UCP1−/− mice. TRPV1 and UCP1 double knockout resulted in dramatically reduced Ca2+mito uptake in low [Ca2+]cyto that was coupled with H+mito extrusion, which affected ATP generation and oxidative stress in BAT mitochondria. TRPV1 knockout caused to a Ca2+mito uptake compensatory rise. The results of our genetic manipulation studies provide in vivo evidence for the pathogenesis of TRPV1 and UCP1 double knockout in mice caused obesity and offer a novel target to manipulate obesity and associated complications.
- 1 September 2016
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 34 (Supplement) , e404
OS 36-09 DEFICIENCY OF THERMOGENESIS AND HEAT SENSATION ACCELERATES OBESITY AND HIGH BLOOD PRESSURE
Obesity is global healthy problem. Uncoupling protein 1 (UCP1) mainly expresses on brown adipose tissue (BAT), uncouples energy substrate oxidation from mitochondrial ATP production and results in the loss of potential energy as heat. Transient receptor potential vanilloid subfamily, member 1 (TRPV1) is the heat-gated cation ion channel. The aim of this study was to investigate the in vivo role of TRPV1 and UCP1 co-action in obesity. We generated and characterized UCP1−/− mice lacking TRPV1 activity (TRPV1−/−/UCP1−/− mice). The core-body temperature and the locomotor activity were simultaneously measured by the telemetry system. The rate of mitochondrial respiration was measured using the Oxygraph-2k. Cytosol superoxide anion was determined by DHE and mitochondrial superoxide anion was measured by MitoSOX. The levels of ATP in primary cultured brown adipocytes were measured using a firefly luciferase-based ATP assay kit. Primary brown adipocytes were cultured and the fluorescence measurements of cells were made using a fluorescent plate reader. TRPV1 and UCP1 double knockout would appear obesity in advance and more severe comparing with WT, TRPV1−/− and UCP1−/− mice. TRPV1 and UCP1 double knockout in mice reduced functional BAT generation to cause BAT white, and decreased lipolysis comparing with the other three groups. TRPV1−/−/UCP1−/− mice significantly decreased resting oxygen consumptions, heat production and locomotor activities. Mitochondrial respiratory function seriously disordered in BAT of TRPV1−/−/UCP1−/− mice. TRPV1 and UCP1 double knockout resulted in dramatically reduced Ca2+mito uptake in low [Ca2+]cyto that was coupled with H+mito extrusion, which affected ATP generation and oxidative stress in BAT mitochondria. TRPV1 knockout caused to a Ca2+mito uptake compensatory rise. The results of our genetic manipulation studies provide in vivo evidence for the pathogenesis of TRPV1 and UCP1 double knockout in mice caused obesity and offer a novel target to manipulate obesity and associated complications.
- 17 April 2015
- Published by Elsevier
Contributors